Pre-Clinical Data

Before a drug can be tested on people; sponsors (drug manufacturers, research institutions, and other organizations that develop drugs) must show FDA results of testing they have done in laboratory animals and what they propose to do for human testing.

Solutions you may be interested in

Pre-clinical stage Development

Transition your research to clinical development seamlessly with our comprehensive pre-clinical development solutions

Clinical Development Strategy

Starting right with a well-thought clinical development plan. We design & align your study with overall medical, access to market, regulatory goals

Regulatory

Design global patient-centric regulatory strategies to ensure expedited product development leading to patient access

Diverse team of professionals smiling, representing expert support at VCLS.

Questions? Get the answers from our expert team

No two product development paths are the same. Talk to our experts about your development challenges and we will provide you actionable recommendations.

Contact Us

Pre-Clinical Data

Pre-Clinical Data

RELATED INSIGHTS

Key CMC and NC considerations for cell and gene therapy development

Ask the Experts: Navigating FDA & EMA CMC Expectations for Cell and Gene Therapy Product Development

Achieve Success for Your First US Product Application – Pathway to IND

Solutions you may be interested in

Pre-clinical stage Development

Clinical Development Strategy

Regulatory

Questions? Get the answers from our expert team ​

Questions? Get the answers from our expert team